Table 2.
Summary of the most important differences and similarities between African swine fever (ASF) and classical swine fever (CSF)
ASF | CSF | Both diseases | |
---|---|---|---|
Virus | |||
Virus taxonomy and morphology | Large DNA virus | Small RNA virus | |
Clinical signs and pathology | Among others high fever, appetite loss, lethargy, erythema, petechiae | ||
Immune response and vaccination | Lack of neutralizing antibodies, no or insufficient cross-protection among strains, protection linked to cytotoxic T-cell responses No vaccination available |
Existence of neutralizing antibodies, cross-protection among genotypes, safe and efficacious vaccines available | |
Epidemiology | |||
Transmission and contagiosity | Direct and indirect transmission | ||
Most effective with blood contact, no evidence for intrauterine transmission | Virus shedding with all se- and excretions, intrauterine transmission and resulting persistent infection of fetuses possible | ||
Vectors and carriers | Wild boar important reservoir | ||
Transmission through ticks possible | No transmission through arthropods or rodents described | ||
Tenacity | Long infectivity in cold environmental temperatures | ||
History and today’s distribution | For long time only endemic in Africa and Sardinia since 2007 present in Europe | Long-term epidemics in wild boar over the last decades, sporadic occurrence in domestic pigs; currently no outbreaks in domestic pigs, no cases reported in wild boar | |
Prevention and control measures | No vaccination | Effective vaccination | |
High biosecurity, no swill feeding, no contact between domestic pigs and wild boar |